| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.935111 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240403125521 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 240308e20240306onc ob f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH113-27/2024-2E-PDF |
|---|
| 245 | 00|aNatamycin and its associated end-use products : |bconsultation document. |
|---|
| 264 | 1|aOttawa, Ontario : |bPest Management Regulatory Agency, Health Canada, |c6 March 2024. |
|---|
| 264 | 4|c©2024 |
|---|
| 300 | |a1 online resource (10 pages). |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 490 | 1 |aProposed re-evaluation decision, |x1925-0967 ; |vPRVD2024-02 |
|---|
| 500 | |aIssued also in French under title: Natamycine et préparations commerciales connexes : document de consultation. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 650 | 0|aAntifungal agents|xCertification|zCanada. |
|---|
| 650 | 0|aAntifungal agents|xRisk assessment|zCanada. |
|---|
| 650 | 0|aAntifungal agents|xHealth aspects. |
|---|
| 650 | 0|aAntifungal agents|xEnvironmental aspects. |
|---|
| 710 | 1 |aCanada. |bPest Management Regulatory Agency, |eissuing body. |
|---|
| 775 | 08|tNatamycine et préparations commerciales connexes : |w(CaOODSP)9.935112 |
|---|
| 830 | #0|aProposed re-evaluation decision (Canada. Pest Management Regulatory Agency)|vPRVD2024-02.|w(CaOODSP)9.505201 |
|---|
| 856 | 40|qPDF|s280 KB|uhttps://publications.gc.ca/collections/collection_2024/sc-hc/h113-27/H113-27-2024-2-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/consumer-product-safety/pesticides-pest-management/public/consultations/proposed-re-evaluation-decisions/2024/natamycin/document.html |
|---|